Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2020-03-16 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated March 16, 2020, addressed to stock exchanges (NSE and BSE) regarding the schedule of upcoming analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which governs disclosure of material events. The content is an intimation about planned investor meetings (conference calls) and explicitly states no unpublished price sensitive information will be shared. The document is brief (2018 characters) and serves as an announcement of scheduled investor interactions rather than containing any financial data, results, or detailed reports. It does not contain financial statements or detailed analysis, nor is it a transcript or presentation. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2020-03-16 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges about the schedule of analyst and institutional investor meetings, including conference calls. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an announcement of upcoming investor meetings and does not contain financial results, detailed presentations, or transcripts. The document length is short (2126 characters), and it serves as an intimation rather than a full report or transcript. Therefore, it fits best under the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other specific categories.
2020-03-09 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification addressed to stock exchanges regarding the schedule of analyst and institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events and information. The content is about informing the exchange and public about upcoming investor meetings and explicitly states that no unpublished price sensitive information will be shared. There are no financial statements, detailed financial data, or report attachments. The document is short (1866 characters) and serves as an announcement rather than a report or detailed presentation. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2020-03-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a short notice dated February 27, 2020, addressed to stock exchanges regarding the schedule of analyst/institutional investor meetings. It references Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosure of material events. The content is an intimation about upcoming meetings, explicitly stating no unpublished price sensitive information will be shared. The document is brief (1581 characters) and serves as an announcement rather than a detailed report or transcript. It does not contain financial data, management discussion, or voting results. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance disclosures that do not fit other categories.
2020-02-27 English
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation Classification · 90% confidence The document is a short notice addressed to stock exchanges about the schedule of an analyst/institutional investor meeting, specifically a one-on-one conference call. It does not contain any financial data, results, or detailed presentations. It is an announcement of a meeting rather than the meeting transcript or report itself. The document length is only 1421 characters, indicating it is a brief notice. Therefore, it fits best under the category of Investor Presentation (IP) or possibly Regulatory Filings (RNS). However, since it is specifically about scheduling an analyst/investor meeting, it aligns most closely with Investor Presentation (IP) as it relates to investor communications and meetings. Confidence is high due to clear mention of analyst/investor meeting schedule and no financial data present.
2020-02-26 English
Date of payment of dividend
Notice of Dividend Amount Classification · 100% confidence The document is a formal letter addressed to stock exchanges announcing the declaration of a 2nd Interim Dividend for the financial year 2019-20. It specifies the dividend amount per share, the record date, and the payment date. The content is focused on dividend declaration details rather than financial results, management changes, or regulatory filings. The document length is short (1661 characters) and it explicitly states the dividend declaration and payment schedule. This matches the definition of a Notice of Dividend Amount (DIV).
2020-02-25 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.